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Potential chemopreventive, 
anticancer and anti‑inflammatory 
properties of a refined 
artocarpin‑rich wood extract 
of Artocarpus heterophyllus Lam.
Isaac J. Morrison1,2,7, Jianan Zhang3,7, Jingwen Lin3, JeAnn E. Murray1, Roy Porter4, 
Moses K. Langat5, Nicholas J. Sadgrove5, James Barker6, Guodong Zhang3 & 
Rupika Delgoda1* 
Colorectal cancer (CRC) represents the third leading cause of death among cancer patients below the 
age of 50, necessitating improved treatment and prevention initiatives. A crude methanol extract 
from the wood pulp of Artocarpus heterophyllus was found to be the most bioactive among multiple 
others, and an enriched extract containing 84% (w/v) artocarpin (determined by HPLC–MS–DAD) 
was prepared. The enriched extract irreversibly inhibited the activity of human cytochrome P450 
CYP2C9, an enzyme previously shown to be overexpressed in CRC models. In vitro evaluations on 
heterologously expressed microsomes, revealed irreversible inhibitory kinetics with an  IC50 value of 
0.46 µg/mL. Time‑ and concentration‑dependent cytotoxicity was observed on human cancerous 
HCT116 cells with an  IC50 value of 4.23 mg/L in 72 h. We then employed the azoxymethane (AOM)/
dextran sodium sulfate (DSS) colitis‑induced model in C57BL/6 mice, which revealed that the enriched 
extract suppressed tumor multiplicity, reduced the protein expression of proliferating cell nuclear 
antigen, and attenuated the gene expression of proinflammatory cytokines (Il-6 and Ifn-γ) and 
protumorigenic markers (Pcna, Axin2, Vegf, and Myc). The extract significantly (p = 0.03) attenuated 
(threefold) the gene expression of murine Cyp2c37, an enzyme homologous to the human CYP2C9 
enzyme. These promising chemopreventive, cytotoxic, anticancer and anti‑inflammatory responses, 
combined with an absence of toxicity, validate further evaluation of A. heterophyllus extract as a 
therapeutic agent.
Colorectal cancer (CRC) ranks as the third most commonly diagnosed cancer in the  US1 and in  Jamaica2, 
and it is the second leading cause of cancer-related deaths in both sexes in the  US1. While CRC is affected by 
modifiable factors such as environment, physical activity, Quetelet’s index, diet, cigarette smoking, and alcohol 
 consumption3, it is of noteworthy concern that it ranks as the third leading cause of death among young cancer 
patients aged 20–49 in the  US4. Approximately 20% of patients diagnosed with colorectal cancer in Jamaica 
between 2008 and 2012 were younger than 50 years  old5. A recent study on a murine model showed that moving 
away from a Western diet even after carcinogenesis may reduce tumor  burden6, demonstrating that incorporat-
ing dietary compounds containing anticancer, antioxidant, and anti-inflammatory properties may have added 
benefits in treating and preventing colorectal cancer. Given that nature has inspired significant solutions to cancer 
therapy in the past four  decades7 and the demonstrated reliance and confidence on ethnomedicines by cancer 
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 patients8, it is imperative that nature’s sources be fully evaluated as novel therapeutic options for the treatment 
and prevention of CRC.
Cytochrome P450 (CYP) enzymes are ubiquitous enzymes considered highly important in the metabolism 
of pharmaceutical  drugs9,10, as well as in the activation of environmental  carcinogens11. The upregulation of CYP 
enzymes in cancer tissue in comparison to surrounding tissue implies their vital role in carcinogenesis, as well as 
in drug  resistance12. The overexpression of CYP2C enzymes in murine induced CRC models, as well as in human 
CRC cell  lines13 and human CRC tissue  samples14, in comparison to their normal counterparts, suggests a role 
for these enzymes in pathogenesis, due most likely to the increased amount of carcinogenic metabolites derived 
from their activities. Indeed, elevated levels of epoxygenated fatty acids in the plasma of mice with induced 
CRC provide evidence for such biomarker  upregulation13. These findings lend support to the search for targeted 
CYP2C inhibitors that could mitigate enzyme activities, thus functioning as  chemopreventors15, in addition to 
the search for prodrugs that rely on activation from elevated metabolic enzyme  activity16.
The Artocarpus genus, comprising nutrient-rich fruits with ethnomedicinal uses in Southeast Asia, Africa, 
Central America, and the Caribbean, demonstrates numerous potential health benefits. Isolated phytochemicals 
including artocarpin, isoartocarpin, cyloartocarpin, artocarpetin, and norartocarpetin were found to have anti-
inflammatory, anticancer, chemopreventive, and antioxidant properties, as well as inhibit the cellular production 
of  melanin17. A previous  study18 revealed the targeted impact of isolated artocarpin on the phosphoinositide 3 
-kinase/Akt pathway, suggesting a chemopreventive role. Yet, there is a dearth of information on its impact on 
cytochrome P450 2C enzymes, previously found to have elevated levels in CRC  models14. Furthermore, a more 
rigorous in vivo study examining the inflammatory response is still needed, particularly through the evaluation 
of a bioactive extract that can display a high safety profile. Hence, we employed a multitarget study design to 
better understand the potential colon cancer-reducing effects of an A. heterophyllus extract. Following numerous 
in vitro evaluations using heterologously expressed human CYP enzymes, as well as human cancer cell lines, 
we used the AOM/DSS model, a chemically induced colitis-associated cancer (CAC) mouse model employing 
azoxymethane (AOM) and dextran sulfate sodium (DSS) carcinogens, which mimics a form of inflammatory 
colorectal cancer in humans, to assess the impact of the A. heterophyllus extract on colon tumor  development19,20.
Results
Identification and standardization of bioactive A. heterophyllus extract. Eight crude extracts 
were prepared from various parts of the A. heterophyllus Lam. plant with n-hexane and methanol. Then, after 
an initial screen for cytotoxicity potential, the crude methanol extract from the wood was identified as the most 
potent. This crude extract was fractionated using column chromatography, which led to 14 semi-purified frac-
tions. Through the application of a cytotoxic assay using a panel of three cell lines (Supplementary Table S1), 
those with potent bioactivity was identified. Accordingly, an enriched extract was prepared using solvent extrac-
tion. The final enriched extract (simply referred to as the A. heterophyllus extract from here on) was quantified 
as containing 84% (w/v) artocarpin using LC–MS (Fig. 1). This was confirmed by NMR analysis and a standard 
curve using the UV absorption of pure artocarpin.
The prepared A. heterophyllus extract was then evaluated for cytotoxicity using the aggressive, human CRC cell 
line, HCT116. Cell viability decreased in a concentration- and time-dependent manner in the presence of the A. 
heterophyllus extract. After 24 h of treatment with the A. heterophyllus extract, an  IC50 value of 9.38 ± 1.26 mg/L 
was obtained, while, after 48 h and 72 h of exposure, the  IC50 decreased by 31% and 55% to 6.48 ± 0.63 and 
4.23 ± 0.08 mg/L, respectively (Fig. 2).
Impact of A. heterophyllus extract on CYP2C enzyme activity in vitro and in vivo. Given the 
putative role of CYP2C enzymes in the pathogenesis of CRC in humans and mice 13, we evaluated the inhibitory 
potential of the A. heterophyllus extract on the activities of human CYP2C9 and 2C19 enzymes. Potent, con-
centration-dependent inhibition was observed against the activity of heterologously expressed human CYP2C9 
with an  IC50 of 0.46 ± 0.02 µg/mL, while moderate inhibition was observed against the activity of CYP2C19, 
with an  IC50 value of 1.71 ± 0.09 µg/mL (Fig. 3a). Further characterization of the inhibition revealed irreversible 
kinetics against CYP2C9 with no return in activity, even after 8 h of dialysis following exposure to the extract 
(Fig. 3b). A shift in  IC50 of 33 units (Fig. 3c) following a 30-min preincubation is suggestive of time-dependent 
kinetics, although further timepoint evaluations are needed to validate such assertions.
The above in vitro evaluations pointed to an effective and potent impact of the wood extract of A. heterophyllus 
Lam. on markers of chemoprevention and cytotoxicity, motivating its further evaluation using an in vivo model. 
We, therefore, implemented the AOM/DSS colitis-induced cancer mouse model to gain additional insight into 
in-vivo efficacy (see scheme of animal experiment in Fig. 4a).
The mice with AOM/DSS colitis-induced cancer who were administered the A. heterophyllus extract displayed 
a marked threefold reduction (p = 0.02) in the expression of Cyp2c37 gene throughout the colon (Fig. 4b), gauged 
by qRT-PCR, in comparison to the vehicle control diet group. This gene was selected due to its high homology 
with the human CYP2C9 gene (as cyp2c9 is not found in mice). The observed reduction in Cyp2c37 gene expres-
sion, along with an inhibitory effect toward the enzyme activity of the human protein product (CYP2C9), suggests 
a potential role for the A. heterophyllus extract in chemoprevention via the CYP2C pathway.
Impact of A. heterophyllus extract on AOM/DSS‑induced colon tumorigenesis. The effect of the 
A. heterophyllus extract containing artocarpin was tested on AOM/DSS-induced colon tumorigenesis in mice. 
The mutagenic activity of AOM requires metabolic activation by  CYP2E121. Thus, the A. heterophyllus extract 
was included in the diet, after allowing the colonic mutagen AOM enough time to be activated by CYP2E1, cou-
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pled with DSS-induced colonic inflammation, thereby mimicking colitis-associated tumorigenesis (see scheme 
of animal experiment in Fig. 4a).
Oral administration of 480 ppm A. heterophyllus extract suppressed AOM/DSS-induced colon tumorigenesis 
by 46.2%. Compared with vehicle-treated AOM/DSS mice, the A. heterophyllus extract-treated mice had a sig-
nificantly (p = 0.0270) lower number of tumors per mouse, particularly those with a diameter of ~ 1 mm (Fig. 5a). 
The extract was well tolerated, with no fatalities observed within the test group. Immunohistochemical staining 
showed that treatment with the A. heterophyllus extract reduced the protein expression of tumorigenic marker 
proliferating cell nuclear antigen (PCNA) in the colon tissues (Fig. 5b). Furthermore, treatment with the A. het-
erophyllus extract significantly reduced the gene expression of a series of protumorigenic and proinflammatory 
genes (Axin2 (p = 0.0379), Pcna (p = 0.0263), Il-6 (p = 0.0174), and Myc (p = 0.0189)), while a substantial (albeit 
Figure 1.  HPLC–MS chromatogram of the A. heterophyllus Lam. extract containing artocarpin (inset).
Figure 2.  Cytotoxicity of the A. heterophyllus extract toward human colon adenocarcinoma HCT116 cells. The 
cells were treated with the A. heterophyllus extract for 24 h, 48 h, and 72 h, and the cell viability, as a percentage 
relative to the solvent (ethanol)-treated control, was measured using the MTT assay as detailed in the methods. 
Data are presented as the mean ± SEM of three independent experiments.
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nonsignificant) decrease in the expression of Ifn-γ (p = 0.0718) and Vegf (p = 0.0767) was seen (Fig. 6). Overall, 
these results demonstrate the anti-CRC effects of the A. heterophyllus extract.
Discussion
Using numerous in vitro and in vivo tools, we herein demonstrate the promising application of a prepared 
botanical wood extract (A. heterophyllus extract, 84% (w/v) artocarpin) in the reduction of tumor multiplicity, 
proinflammatory biomarkers, and gene expression and activities of cytochrome P450 2C enzymes, indicative 
of potential chemoprevention.
The extract was well tolerated in mice with 100% survival for the duration of this study, similar to previous 
studies involving the active component artocarpin, which suggests an acceptable safety  profile18. Furthermore, 
cytotoxicity to cancer cells was observed using HCT116 colorectal cells with  IC50 values < 10 mg/L (6.48 mg/L), 
along with less than half such impact on normal colon cell line CCD-18Co with an IC50 value of 17.8 mg/L, 
over a 48 h period. These values compared well with previous estimations of  IC50 for purified artocarpin treated-
colorectal cell lines SW480, HT-29, HCT15, and HCT116 with  IC50 values of ~ 15 µM (or 6.55 mg/L) at 48 h, 
along with a nominal impact on the normal colon cell line CCD-18Co18. A time- and concentration-dependent 
effect on HCT116 cells was illustrated by the drop in  IC50 after 48 h (6.48 ± 0.63 mg/L) and 72 h (4.23 ± 0.08 mg/L) 
in comparison to the value at 24 h (9.38 ± 1.26 mg/L), suggesting the likely exploitation of a pathway impacting 
cellular replication by the extract or its metabolites. Previously, artocarpin was proven to be cytotoxic toward a 
wide range of other cancer cells lines, including breast (T47D and MCF-7), bone (U-2 OS, MG63, and HOS), 
Figure 3.  Inhibitory effects of the A. heterophyllus extract on human CYP2C9-mediated 7-methoxy-4-
trifluoromethylcoumarin demethylase (80 µM) and CYP2C19-catalyzed 3-cyano-7-ethoxycoumarin deethylase 
(25 µM) in vitro activities. (a) A. heterophyllus extract concentration-dependent inhibition of CYP2C9 and 
CYP2C19 activities. Control activities performed with methanol (mean ± SEM) for CYP2C9 and 2C19 were 
5.84 ×  10−4 ± 3.56 ×  10−5 and 8.01 ×  10−3 ± 2.83 ×  10−4 µM metabolite formed per min/pmol of CYP, respectively. 
(b) Effect of dialysis on the inactivation of human recombinant CYP2C9 activity by the A. heterophyllus extract. 
For (a) and (b), each data point is the mean percentage of control enzyme activity for three independent 
experiments. A p value ≤ 0.05 was considered statistically significant. (c) Effect of preincubation in the presence 
or absence of NADPH on the inhibition of human recombinant CYP2C9 activity by the A. heterophyllus extract.
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Figure 4.  qRT-PCR evaluation of the Cyp2c37 gene expression in vivo. (a) Scheme of animal experiment. (b) 
qRT-PCR analysis of Cyp2c37 gene expression in colon tissues. The results are expressed as the mean ± SEM, 
n = 11 mice in Ctrl group and n = 10 mice in the A. heterophyllus group. Ctrl, vehicle control.
Figure 5.  The Artocarpus heterophyllus extract suppresses AOM/DSS-induced colon tumorigenesis in mice. (a) 
Quantification of colon tumorigenesis in mice. Dissected colons were examined for number and dimension of 
tumors in each group and categorized on the basis of diameter (approximately 1 mm, 2 mm, and total sum). (b) 
H&E staining and immunochemical staining of PCNA in the colon scale bar=100μm. The results are expressed 
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colon (SW480, HT-29, and HCT15), lung (A549), prostate (PC-3), and the CNS (U-87, MGU87, and U118)18,22–26, 
in addition to in vivo efficacy in breast, bone, colon, and prostate  models18,22,26–28.
Recently, Wang and  colleagues13 found that the expression of CYP2C9 and CYP2C19 (both mRNA and 
protein) was elevated in human colon cancer HCT116 and Caco-2 cells in comparison to the normal cell line 
CCD-18Co; they also demonstrated that targeted inhibitors could aid in mitigating tumorogenesis in mice. Our 
current results provide evidence that the presence of the A. heterophyllus extract could mitigate the in vivo gene 
expression of Cyp2c37 and reduce the in vitro activities of human recombinant CYP2C9 and 2C19 isoforms, 
thereby providing strong evidence for its inhibitory and antagonistic effect on CYP2C9’s role in CRC. Modula-
tion of CYP gene expression, as well as the direct binding to and inhibition of overexpressed enzymes in cancer, 
could lead to mitigation of carcinogenesis and tumor  progression29. We also found that the extract behaves as 
an irreversible inhibitor (Fig. 3), providing it with the potential advantage of a lasting impact. Future studies 
considering chronic exposure and its impact on co-administered drugs reliant on CYP2C9  metabolism9 would 
allow expanding its safety profile.
Following the promising in vitro results, we embarked on a study of the impact of the A. heterophyllus extract 
in the AOM/DSS mouse model. The results obtained herein show that oral administration of the A. heterophyl-
lus extract, as the component of a diet fed to AOM/DSS-induced colon tumorigenesis mice, reduced tumor 
multiplicity, consistent with the findings of a previous study utilizing a pure artocarpin  gavage18. Moreover, 
according to Fig. 6, the expression of proinflammatory and protumorigenic genes (Axin2, Ifn-γ, and C-myc) was 
downregulated, partially supporting a previous murine study which showed that topical application of artocarpin 
resulted in the decreased protein expression of proinflammatory cytokines IL-1β and TNF-α30. While there 
was a decrease in the genetic expression of Il-1β and Tnf-α in this study, it was not significant (data not shown).
Previous research has suggested the arachidonic acid/COX-2 pathway via CYP activation as a key player in 
the inflammatory response driving colitis-associated colon  tumorigenesis13,30. Furthermore, a previous in vitro 
experiment determined that artocarpin, like celecoxib, acts as a COX-2 inhibitor with anti-inflammatory prop-
erties, which, in the presence of AOM/DSS, results in an increase in inflammatory  response18,31. DSS-induced 
colitis, caused by the microrupture of colon epithelial tissue, is characterized by the infiltration of immune cells 
as an inflammatory  response32,33. We identified a decrease in the gene expression of proinflammatory cytokine 
Il-6 and chemokine Ifn-γ (Fig. 6) in mice fed the A. heterophyllus extract. Artocarpin, as one of numerous Arto-
carpus spp.-derived phytochemicals, has been shown in numerous studies to behave as an anti-inflammatory 
and anticancer agent, which suggests a potential role in addressing the inflammation seen in colitis-associated 
 cancer27,34. These results demonstrate that, while the extract could repress the proinflammatory response, its 
antitumor effects, similar to celecoxib, may not depend solely on its anti-inflammatory  properties31,35.
There was a significant reduction in tumor proliferation, as well as a reduction in crypt cells marked by PCNA 
staining. Additionally, H&E staining of colon tissue showed greater inflammation in control mice, suggesting that 
treatment with the A. heterophyllus extract aids in the recovery from AOM/DSS-associated colitis tumorigenesis.
In summary, the administration of an extract from A. heterophyllus Lam., standardized to contain 84% (w/v) 
artocarpin, effectively suppressed tumor multiplicity and inflammation in AOM/DSS-induced mouse colon via 
Figure 6.  Expression of proinflammatory and protumorigenic genes in the colon after treatment with the 
Artocarpus heterophyllus extract. The results are expressed as the mean ± SEM, n = 11 mice in Ctrl group and 
n = 10 mice in the A. heterophyllus group. Ctrl, vehicle control.
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decreasing the expression of cytokine Il-6. Additionally, the reduced expression of the Cyp2c37 gene in mice 
and the potent inhibition toward the activity of human CYP2C9, an upregulated isoform in colon cancer cells, 
point to the chemopreventive potential of this extract. Taken together, the A. heterophyllus extract with its active 
component, artocarpin, displays promising anti-inflammatory, anticancer, and chemopreventive properties and 
may be a lead molecule for treating colitis-associated tumorigenesis.
Materials and methods
Preparation of crude polar and nonpolar plant extracts. Artocarpus heterophyllus Lam. (Voucher # 
36378), collected at the Botany Gardens, the University of the West Indies, Mona-Campus, Jamaica, was authen-
ticated by Mr Patrick Lewis, the local herbarium curator. Oven-dried wood chips (1200  g), fruit rind chips 
(323 g), ground testa (24 g), and seeds (170 g) were exhaustively extracted with n-hexane and then methanol, at 
least 3 times. Crude extracts were concentrated to dryness in vacuo on a rotary evaporator (Heidolph Laborota 
4000 efficient and BUCHI water bath B-481) below 55 °C, and they were stored at − 20 °C in aluminum-wrapped 
glass vials until reconstituted in appropriate solvents for cytotoxicity evaluation.
Semi‑purification of crude methanol extract via silica gel column chromatography. Following 
the determination of optimum cytotoxicity, the methanol crude extract of the wood chips (red–orange gum, 
3 g) was subjected to further separation using silica gel 60 Å (230–400 mesh (40–63 μm) particle size, SiliCycle 
Inc., Quebec City, QC, Canada) gravity column chromatography. The crude methanol wood extract was added 
to the column (60 × 6 cm) and eluted with 90% n-hexane with increasing concentrations of ethyl acetate. This 
was followed by neat ethyl acetate, which was gradually enriched with methanol to a maximum concentration 
of 75% (v/v), to produce 14 different semi-purified fractions (I–XIV). These were monitored using TLC via 
molybdenum spray detection and combined according to Rf values. The fractions were concentrated, and the 
resulting powdered extracts were stored as previously described, before subsequent use in cytotoxicity evalu-
ation against colorectal (HT29), prostate (PC3), and liver (HepG2) cancer cell lines (Table S1), subject to the 
quantity of material available.
Preparation and standardization of an enriched A. heterophyllus extract. Guided by the condi-
tions that yielded the most potent fractions from chromatographic separation (above), an enriched extract was 
prepared, as briefly described  elsewhere36. Oven-dried wood chips (2.5 kg) of A. heterophyllus Lam. were exhaus-
tively defatted with n-hexane and then differentially re-extracted in methanol in amber containers. The methanol 
crude extract (21.2 g, yield: 0.85%), concentrated as previously described, was suspended in water and subjected 
to successive portioning with equivalent volumes of n-hexane followed by methylene chloride. The methylene 
chloride portion was subsequently recrystallized with ethyl acetate/hexane, producing a yellow-orange powder 
(referred to as the A. heterophyllus extract, 4.5 g, yield: 0.18%), standardized for artocarpin (Fig. 1) and stored 
at − 20 °C in an aluminum-wrapped glass vial until further use.
To quantitatively determine artocarpin content in the extract, it was dissolved to a concentration of 1.53 mg/
mL in methanol, before injecting 2 µL into a quantitative high-performance liquid chromatograph (HPLC) mass 
spectrometer (MS) equipped with UV diode array detection (DAD) (Velos-Pro, Thermo Fisher Scientific). A 
Phenomenex C18 column (150 × 3 mm, 3 μm particle size) was used as the stationary phase, and the mobile 
phase at a flow rate of 0.4 mL/min was applied as follows: 0–1 min = isocratic gradient 10% acetonitrile in  H2O; 
1–20 min = linear gradient 10% acetonitrile in  H2O to 10% acetonitrile in methanol. Pure artocarpin (BOC 
Sciences NY, USA) was used to produce a calibration curve at concentrations of 1.1 mg/mL, 0.55 mg/mL, and 
0.257 mg/mL, using 2 µL injections. Concentrations were calculated from the integrated UV peak areas at a 
wavelength of 256 nm. HPLC-grade solvents were used.
In vitro CYP P450 enzyme assays. High-throughput fluorometric inhibition assays performed in 96-well 
microtiter plates were used to evaluate the inhibitory capacity of the A. heterophyllus extract on human CYP2C 
enzyme activity. Catalytic activities describing the CYP2C9-mediated conversion of 7-methoxy-4-trifluoro-
methylcoumarin (MFC) demethylase (80 µM) to fluorescent 7-hydroxy-4-trifluoromethyl-coumarin (HFC) and 
3-cyano-7-ethoxycoumarin (CEC) deethylase (25 µM) to fluorescent 3-cyano- 7-hydroxycoumarin (CHC)37,38 
were monitored. For inhibition assays, the incubating mixture contained CYP2C9 (Cypex Ltd.) (2.5  pmol) 
and CYP2C19 (Cypex Ltd.) (1.0 pmol), in 0.1 M potassium phosphate buffer (KPB, pH 7.4) in a final volume 
of 0.2 mL, which was prewarmed for 10 min, unless otherwise  stated37. Following the appropriate incubation 
period (CYP2C9, 45 min and CYP2C19, 30 min), 75 μL of 80% acetonitrile/20% Tris base (0.5 M) was added to 
stop the reaction. Fluorescence generated from the formation of CHC or HFC was recorded using a Varian Cary 
Eclipse Fluorescence Spectrophotometer microplate reader with excitation/emission wavelengths of 409/460 nm 
and 405/530 nm, respectively. Methanol (1.5% v/v) was used as a negative control.
Direct inhibition studies (IC50 determination). The prewarmed A. heterophyllus extract was serially 
diluted (23.27–0.01 µg/mL) in tubes containing human CYP2C enzymes and their respective substrates, at con-
centrations equal to their  Km  values37. NADPH (43 µM) was added to initiate the reaction. After terminating the 
reaction, fluorescence data were measured and converted to CYP activity ± SEM as a percentage of the control 
using Microsoft Excel (2002).  IC50 values were determined by fitting the average % CYP activity ± SEM with a 
four-parameter logistic (4PL) nonlinear regression model, using SigmaPlot 10.0 from Systat Software Inc., San 
Jose California USA, www. systa tsoft ware. com.
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where Min and Max are the minimal and maximal observed effects, respectively, x is the concentration of the 
test agent, and  IC50 is the half-maximal inhibitory concentration.
In order to determine the kinetics of the A. heterophyllus extract on CYP2C9 activity, dialysis, and  IC50 
shift assays were carried out. To evaluate reversibility, CYP2C9 was preincubated with an  IC75 concentration of 
extract in a Pur-A-Lyzer™ Midi 60,010 dialysis unit (Sigma Aldrich) or microcentrifuge tube for 8 h at 4 °C. The 
residual enzyme activity of the incubation mixtures pre and post dialysis was expressed as a percentage of their 
respective vehicle controls (0.18% methanol). For the  IC50 shift assay, the A. heterophyllus extract in the pres-
ence of CYP2C9 (5 pmol) was directly incubated with substrate (160 µM) or first preincubated with or without 
NADPH for 30 min.
Cell lines and culture. The human colon adenocarcinoma cell line HCT116 (ATCC, CCL-247) and normal 
cell line CCD-18Co (ATCC, CRL-1459) were cultured in DMEM, supplemented with 10% fetal bovine serum, 
and maintained under standard cell culture conditions at 37 °C and 5%  CO2 in a humidified  incubator39. To rule 
out specificity to one type of colon cancer cell, the aggressive HCT116 cell line was used, as HT29 cells were 
employed earlier in the study (Table S1).
Cell viability assay. Viable cells were quantified using a tetrazolium-based colorimetric 3‐(4,5‐dimeth-
ylthiazol‐2‐yl)‐2,5‐diphenyl‐2H‐tetrazolium bromide (MTT) assay, by determining the amount of formazan 
crystals produced by metabolically active  cells40,41. Following 24 h of incubation, cells seeded into 96-well plates 
(1–1.5 ×  103 cells per well) were exposed to the A. heterophyllus extract or ethanol (3% v/v) for a further 24, 48, 
or 72 h. After disposal of used medium, MTT in fresh medium (0.5 mg/mL) was added to each well. The plate 
was incubated for 1–2 h, after which the medium was discarded and the formed formazan crystals were dis-
solved in DMSO (100 µL). The absorbance of cells was measured at 570 nm using a BioTek Synergy 2 microplate 
spectrophotometer with Gen5 Software (Bio-Tek). The data are presented as the percentage of viable cells using 
SigmaPlot 10.0, and the  IC50 values were determined.
Animal experiments. The mouse experiments were conducted in accordance with the protocols approved 
by the Institutional Animal Care and Use Committee of the University of Massachusetts Amherst (protocol 
number: 2017–0019) with mice maintained in a specific pathogen-free (SPF) facility of the University of Mas-
sachusetts (Amherst, MA). C57BL/6 male mice (age: 6 weeks) were purchased from Charles River (Cambridge, 
MA). All methods involving animals are reported in accordance with ARRIVE  guidelines42.Upon arrival, the 
mice were allowed free access to water and a chow diet for 1 week acclimation. Afterward, mice were treated 
with 10 mg/kg AOM (Sigma Aldrich) via intraperitoneal injection, and at week 1 post AOM injection, they were 
given 2% DSS (36–50 kDa, MP Biochemicals) in drinking water for 1 week. Mice were then randomly assigned 
to two groups (n = 11 in control group, (mean ± SEM) body weight = 23.02 ± 0.39 g; and n = 10 in A. heterophyl-
lus group, (mean ± SEM) body weight = 22.94 ± 0.46 g) and maintained ad libitum on a modified AIN-9G diet 
(containing 10% fat). Corn oil was the only source of fat content, and the diet composition, as described in Sup-
plementary Table S2, contained 480 mg of A. heterophyllus extract/kg diet dissolved in polyethylene glycol 400 
(PEG 400, Millipore) as a vehicle (0.1% in diet, v/w) or vehicle alone for 6 weeks. All ingredients except the corn 
oil and A. heterophyllus extract were purchased from Dyets Inc. Bethlehem, PA. The diets were freshly prepared 
and changed twice weekly. At week 8 post AOM injection, the mice were sacrificed, and colon tissues were col-
lected for analysis. Colon tissues were cut open longitudinally, washed in PBS, and inspected under a dissecting 
microscope. The size of the tumors was determined using the following formula: tumor size = π ×  d2/4, where d 
is the diameter of each tumor. Tissue staining and qRT-PCR analysis of gene expression in colon tissues were 
carried out according to protocols described in the Supplementary Materials and Methods using the RT-PCR 
primers listed in Supplementary Table S3.
Statistical analysis. Data are expressed as the mean ± SEM. Significance comparisons for in vitro data were 
performed using a two-tailed Student t-test with data analysis performed using SigmaPlot 10.0, while compari-
sons between two groups (in vivo) were performed using the Mann–Whitney test with data analysis performed 
using Prism 6 (GraphPad Software). A p value < 0.05 was considered as statistically significant.
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